---
schema_version: "secwatch.filing_event.v1"
accession: "0001607062-21-000331"
form_type: "8-K"
ticker: "RGBP"
cik: "0001589150"
company_name: "Regen BioPharma Inc"
filed_at: "2021-09-16T23:59:59+00:00"
generated_at: "2026-06-29T03:14:42.291507+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Regen Biopharma settles ChemDiv lawsuit for $800k, contingent on SEC filing by Sept 24

## Summary
- Regen to pay $800k lump sum by Sept 30, 2021, to settle ChemDiv's breach-of-contract lawsuit over ~$1.2M unpaid invoices.
- Settlement contingent on Regen filing acceptable SEC documents by Sept 24 to maintain listing status.
- Upon payment, ChemDiv dismisses litigation with prejudice and transfers NR2F6 research data, compounds, and IP to Regen and Zander.
- If payment not made by Sept 30, agreement void and litigation continues with trial set for Oct 29, 2021.

## SEC filing metadata
- accession: 0001607062-21-000331
- form_type: 8-K
- ticker: RGBP
- cik: 0001589150
- company_name: Regen BioPharma Inc
- filed_at: 2021-09-16T23:59:59+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1589150/000160706221000331/0001607062-21-000331-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1589150/000160706221000331/rgbp091521form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001607062-21-000331
- JSON: https://secwatch.observer/filing/0001607062-21-000331.json
- Plain text: https://secwatch.observer/filing/0001607062-21-000331.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.